Dow Down0.17% Nasdaq Down0.28%

Acorda Therapeutics, Inc. (ACOR)

-NasdaqGS
33.88 Down 1.81(5.07%) Sep 30, 4:00PM EDT
|After Hours : 33.20 Down 0.68 (2.01%) Sep 30, 5:28PM EDT
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingDec 31, 2013Dec 31, 2012Dec 31, 2011
Total Revenue 336,430   305,814   292,237  
Cost of Revenue66,643  57,641  66,567  
Gross Profit 269,787   248,173   225,670  
Operating Expenses
Research Development53,877  53,881  42,108  
Selling General and Administrative185,545  168,690  148,508  
Non Recurring -   -   -  
Others -   -   -  
Total Operating Expenses -   -   -  
Operating Income or Loss 30,365   25,602   35,054  
Income from Continuing Operations
Total Other Income/Expenses Net668  546  534  
Earnings Before Interest And Taxes31,033  26,148  35,588  
Interest Expense2,170  1,880  3,570  
Income Before Tax28,863  24,268  32,018  
Income Tax Expense12,422  (130,690)1,413  
Minority Interest -   -   -  
Net Income From Continuing Ops16,441  154,958  30,605  
Non-recurring Events
Discontinued Operations -   -   -  
Extraordinary Items -   -   -  
Effect Of Accounting Changes -   -   -  
Other Items -   -   -  
Net Income 16,441   154,958   30,605  
Preferred Stock And Other Adjustments -   -   -  
Net Income Applicable To Common Shares 16,441   154,958   30,605  

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.